Oncternal Therapeutics (ONCT) Q2 2024 Earnings

May 9Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-3.11
-2.12
-1.13
-0.14

Details

Expected EPS
-2.8775
Actual EPS
-2.83
Surprise EPS
0.05
Surprise Percent
+1.65%

Description

⁨Oncternal Therapeutics⁩ (⁦ONCT⁩) has reported earnings of ⁦-2.83⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts